Maine legislation · 132nd Legislature
Maine LD178: An Act Regarding Coverage for Step Therapy for Metastatic Cancer
Status: Signed into law, July 1, 2025
What the bill says
An Act Regarding Coverage for Step Therapy for Metastatic Cancer.
From the engrossed text:
An Act Regarding Coverage for Step Therapy for Metastatic Cancer Sec. 1. 24-A MRSA §4320-N, sub-§1, ¶A-1 is enacted to read: A-1. "Associated conditions" means the symptoms or side effects associated with metastatic cancer or its treatment and that, in the judgment of the health care practitioner, further jeopardize the health of a patient if left untreated. Sec. 2. 24-A MRSA §4320-N, sub-§1, ¶C-1 is enacted to read: C-1. "Metastatic cancer" means cancer that has spread from the primary or original site of the cancer to nearby tissues, lymph nodes or other areas or parts of the body. Sec. 3. 24-A MRSA §4320-N, sub-§8 is enacted to read: 8. Step therapy for metastatic cancer and associated conditions prohibited. Notwithstanding subsection 6, paragraph B, with respect to coverage of a prescription drug on a carrier's formulary for the treatment of metastatic cancer and associated conditions, a carrier or utilization review organization may not require that the enrollee use a step therapy protocol before the carrier provides coverage of a prescription drug approved by the United States Food and Drug Administration. Sec. 4. Appropriations and allocations. The following appropriations and allocations are made. ADMINISTRATIVE AND FINANCIAL SERVICES, DEPARTMENT OF Departments and Agencies - Statewide 0016 Initiative: Provides funding to allow enrollees to use step therapy protocols before the carrier provides coverage of …
Sponsors
- Kristi Mathieson (D, 151) · primary sponsor
- Sally Cluchey (D, 52)
- Denise Tepler (D, 24)
Latest actions
- : On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table PASSED TO BE ENACTED in concurrence.
- : On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence.
- : PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.
- : Report READ and ACCEPTED, in concurrence.READ ONCE.Committee Amendment "A" (H-272) READ and ADOPTED, in concurrence.Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (H-272), in concurrence.Ordered sent down forthwith.
- : CONSENT CALENDAR - FIRST DAYUnder suspension of the rules CONSENT CALENDAR - SECOND DAY.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-272).Sent for concurrence. ORDERED SENT FORTHWITH.
- : Carried over, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.
- : The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES in concurrence
- : Committee on Health Coverage, Insurance and Financial Services suggested and ordered printed. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES.Sent for concurrence. ORDERED SENT FORTHWITH.
Subjects: INSURANCE, Legislature, METASTATIC CANCER, Senate, Other, HEALTH INSURANCE
Common questions
- What is LD178?
- LD178 is a bill in the Maine Legislature (132nd Legislature): An Act Regarding Coverage for Step Therapy for Metastatic Cancer.
- What does LD178 do?
- In its own words: An Act Regarding Coverage for Step Therapy for Metastatic Cancer.
- What is the status of LD178?
- Signed into law as of July 1, 2025. Latest action: On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table PASSED TO BE ENACTED in concurrence. (June 25, 2025).
- Who sponsored LD178?
- Kristi Mathieson (D, 151), with 2 co-sponsors.
- Where is the official record for LD178?
- On the Maine Legislature website: https://legislature.maine.gov/legis/bills/display_ps.asp?LD=178&snum=132
Source: official Maine record. Tracked by Delilah, AI for legislation across all 50 states and Congress.